Literature DB >> 25260852

Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features.

Marcello Moccia1, Lorena Mosca2, Roberto Erro3, Mariarosaria Cervasio4, Roberto Allocca1, Carmine Vitale5, Antonio Leonardi6, Ferdinando Caranci7, Maria Laura Del Basso-De Caro4, Paolo Barone8, Silvana Penco9.   

Abstract

The cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is because of NOTCH3 mutations affecting the number of cysteine residues. In this view, the role of atypical NOTCH3 mutations is still debated. Therefore, we investigated a family carrying a NOTCH3 nonsense mutation, with dominantly inherited recurrent cerebrovascular disorders. Among 7 family members, 4 received a clinical diagnosis of CADASIL. A heterozygous truncating mutation in exon 3 (c.307C>T, p.Arg103X) was found in the 4 clinically affected subjects and in one 27-year old lady, only complaining of migraine with aura. Magnetic resonance imaging scans found typical signs of small-vessel disease in the 4 affected subjects, supporting the clinical diagnosis. Skin biopsies did not show the typical granular osmiophilic material, but only nonspecific signs of vascular damage, resembling those previously described in Notch3 knockout mice. Interestingly, messenger RNA (mRNA) analysis supports the hypothesis of an atypical NOTCH3 mutation, suggesting a nonsense-mediated mRNA decay. In conclusion, the present study broadens the spectrum of CADASIL mutations, and, therefore, opens new insights about Notch3 signaling.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CADASIL; Dementia; Genetic; NOTCH3; Stroke

Mesh:

Substances:

Year:  2014        PMID: 25260852     DOI: 10.1016/j.neurobiolaging.2014.08.021

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  9 in total

1.  Clinical features and mutation spectrum in Chinese patients with CADASIL: A multicenter retrospective study.

Authors:  Sheng Chen; Wang Ni; Xin-Zhen Yin; Han-Qiu Liu; Cong Lu; Qiao-Juan Zheng; Gui-Xian Zhao; Yong-Feng Xu; Lei Wu; Liang Zhang; Ning Wang; Hong-Fu Li; Zhi-Ying Wu
Journal:  CNS Neurosci Ther       Date:  2017-07-14       Impact factor: 5.243

2.  A novel frameshift variant in the CADASIL gene NOTCH3: pathogenic or not?

Authors:  V Schubert; B Bender; M Kinzel; N Peters; T Freilinger
Journal:  J Neurol       Date:  2018-03-29       Impact factor: 4.849

Review 3.  Notch3 Signaling and Aggregation as Targets for the Treatment of CADASIL and Other NOTCH3-Associated Small-Vessel Diseases.

Authors:  Dorothee Schoemaker; Joseph F Arboleda-Velasquez
Journal:  Am J Pathol       Date:  2021-04-22       Impact factor: 4.307

4.  Therapeutic antibody targeting of Notch3 signaling prevents mural cell loss in CADASIL.

Authors:  Arturo I Machuca-Parra; Alexander A Bigger-Allen; Angie V Sanchez; Anissa Boutabla; Jonathan Cardona-Vélez; Dhanesh Amarnani; Magali Saint-Geniez; Christian W Siebel; Leo A Kim; Patricia A D'Amore; Joseph F Arboleda-Velasquez
Journal:  J Exp Med       Date:  2017-07-11       Impact factor: 14.307

5.  CADASIL: Ultrastructural insights into the morphology of granular osmiophilic material.

Authors:  Teresa Lorenzi; Michele Ragno; Francesca Paolinelli; Clara Castellucci; Marina Scarpelli; Manrico Morroni
Journal:  Brain Behav       Date:  2017-02-22       Impact factor: 2.708

Review 6.  Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects.

Authors:  Ilaria Di Donato; Silvia Bianchi; Nicola De Stefano; Martin Dichgans; Maria Teresa Dotti; Marco Duering; Eric Jouvent; Amos D Korczyn; Saskia A J Lesnik-Oberstein; Alessandro Malandrini; Hugh S Markus; Leonardo Pantoni; Silvana Penco; Alessandra Rufa; Osman Sinanović; Dragan Stojanov; Antonio Federico
Journal:  BMC Med       Date:  2017-02-24       Impact factor: 8.775

7.  Ex Vivo Models to Decipher the Molecular Mechanisms of Genetic Notch Cardiovascular Disorders.

Authors:  Tommaso Ristori; Marika Sjöqvist; Cecilia M Sahlgren
Journal:  Tissue Eng Part C Methods       Date:  2021-02-17       Impact factor: 3.056

8.  Naturally occurring NOTCH3 exon skipping attenuates NOTCH3 protein aggregation and disease severity in CADASIL patients.

Authors:  Gido Gravesteijn; Johannes G Dauwerse; Maurice Overzier; Gwendolyn Brouwer; Ingrid Hegeman; Aat A Mulder; Frank Baas; Mark C Kruit; Gisela M Terwindt; Sjoerd G van Duinen; Carolina R Jost; Annemieke Aartsma-Rus; Saskia A J Lesnik Oberstein; Julie W Rutten
Journal:  Hum Mol Genet       Date:  2020-07-21       Impact factor: 6.150

Review 9.  Notch3 in Development, Health and Disease.

Authors:  Samira Hosseini-Alghaderi; Martin Baron
Journal:  Biomolecules       Date:  2020-03-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.